Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks
Titel:
Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks
Auteur:
Buti, M. Wedemeyer, H. Aleman, S. Chulanov, V. Morozov, V. Sagalova, O. Stepanova, T. Gish, R. G Lloyd, A. Kaushik, A. M Suri, V. Manuilov, D. Osinusi, A. O Flaherty, J. Pandey, S. Singh, B. Lampertico, P.